Krsnaa Diagnostics Share Price

The revenue zoomed 11.50% to Rs. 1207.18 millions for the quarter ended September 2022 as compared to Rs. 1082.63 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended September 2022 rise to 43.35% to Rs. 179.73  millions  compared to R. 125.38 millions in corresponding previous quarter.OP of the company witnessed a marginal growth to 384.13 millions from 351.66 millions in the same quarter last year.

The September 2022 quarter revenue stood at Rs. 1207.18 millions, up 11.50% as compared to Rs. 1082.63 millions during the corresponding quarter last year.A good growth in profit of 43.35% reported to Rs. 179.73  millions over Rs. 125.38 millions of corresponding previous quarter.Operating profit surged to 384.13 millions from the corresponding previous quarter of 351.66 millions.

The revenue for the December 2022 quarter is pegged at Rs. 1157.36 millions, about 8.87% up against Rs. 1063.11 millions recorded during the year-ago period.The Net Profit of the company registered a slight decline of -2.12% to Rs. 168.65  millions from Rs. 172.31 millions.Operating Profit saw a handsome growth to 383.30 millions from 352.31 millions in the quarter ended December 2022.

A fair growth of 8.87% in the revenue at Rs. 1157.36 millions was reported in the December 2022 quarter as compared to Rs. 1063.11 millions during year-ago period.The Net Profit of the company registered a slight decline of -2.12% to Rs. 168.65  millions from Rs. 172.31 millions.OP of the company witnessed a marginal growth to 383.30 millions from 352.31 millions in the same quarter last year.

The company will strengthen its footprint across Maharashtra, Himachal Pradesh, Punjab, West Bengal, and Rajasthan

Krsnaa Diagnostics is currently trading at Rs. 486.95, up by 3.85 points or 0.80% from its previous closing of Rs. 483.10 on the BSE.

The scrip opened at Rs. 480.05 and has touched a high and low of Rs. 498.95 and Rs. 467.60 respectively. So far 4578 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 835.00 on 11-Oct-2021 and a 52 week low of Rs. 455.00 on 29-Aug-2022.

Last one week high and low of the scrip stood at Rs. 503.85 and Rs. 467.60 respectively. The current market cap of the company is Rs. 1527.81 crore.

The promoters holding in the company stood at 27.38%, while Institutions and Non-Institutions held 31.63% and 40.98% respectively.

Krsnaa Diagnostics is planning to launch 600 diagnostics centers across India. The company will strengthen its footprint across Maharashtra, Himachal Pradesh, Punjab, West Bengal, and Rajasthan, with the spread across metros, tier 2 and tier 3 cities.

The centers will be equipped to offer specialized services in precision medicine, genetics, genomics, and molecular diagnostics, along with the routine investigations of biochemistry and serology, which are commonly used in routine diagnostics tests. The centers will offer dedicated services for women’s health (hormones/ PCOD), diabetes monitoring, cardiac health, and cancer care.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

Out of 8 Diagnostics Centers to be established as a part of the Agreement with Department of Medical, Health & Family Welfare GOUP

Krsnaa Diagnostics is currently trading at Rs. 478.25, up by 1.00 points or 0.21% from its previous closing of Rs. 477.25 on the BSE.

The scrip opened at Rs. 486.25 and has touched a high and low of Rs. 488.20 and Rs. 478.25 respectively. So far 766 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 799.90 on 11-Jan-2022 and a 52 week low of Rs. 455.00 on 29-Aug-2022.

Last one week high and low of the scrip stood at Rs. 488.95 and Rs. 474.90 respectively. The current market cap of the company is Rs. 1498.45 crore.

The promoters holding in the company stood at 27.80%, while Institutions and Non-Institutions held 24.49% and 47.72% respectively.

Krsnaa Diagnostics has operationalized 1 diagnostics center at Lokbandhu Hospital, Lucknow Uttar Pradesh out of 8 Diagnostics Centers to be established as a part of the Agreement with Department of Medical, Health & Family Welfare, Government of Uttar Pradesh (GOUP).

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

Pursuant to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Krsnaa Diagnostics has informed that the schedule of Analyst/Institutional Investor meet to be held on 19th December, 2022 with Ventura Securities in the form of One-on-One Interaction. The Schedule is subject to change which may happen due to exigencies on the part of Analyst/ Institutional Investor or the Company.

The above information is a part of company’s filings submitted to BSE.

Pursuant to the provisions of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Krsnaa Diagnostics has informed that it enclosed the certificates for the quarter ended 31st December, 2022, received from KFin Technologies (Formerly known as KFin Technologies (SEBI Registration Number INR000000221), Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.

The company has operationalized diagnostics center at Ferozepur, Gurdaspur, Nawanshahr and Kapurthala

Krsnaa Diagnostics is currently trading at Rs. 422.60, up by 1.65 points or 0.39% from its previous closing of Rs. 420.95 on the BSE.

The scrip opened at Rs. 417.30 and has touched a high and low of Rs. 423.45 and Rs. 415.15 respectively. So far 1162 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 725.80 on 20-Jan-2022 and a 52 week low of Rs. 415.45 on 18-Jan-2023.

Last one week high and low of the scrip stood at Rs. 438.65 and Rs. 415.45 respectively. The current market cap of the company is Rs. 1321.21 crore.

The promoters holding in the company stood at 27.80%, while Institutions and Non-Institutions held 23.55% and 48.66% respectively.

Krsnaa Diagnostics has operationalized diagnostics center at four more locations i.e. Ferozepur, Gurdaspur, Nawanshahr and Kapurthala in the state of Punjab, as a part of the Agreement with the Government of Punjab for procurement, operation and maintenance of 25 CT Scanners, 6 new MRI Machines, 30 Pathological Laboratories, 1 Referral Laboratory and 95 Collection Centers across the State of Punjab.

With this, the company has operationalized 24 CT Scanners, 6 MRI Machines, 30 Pathology Labs including 1 Referral Laboratory and 95 Collection Centers in the State of Punjab which amounts to completion of 99% of the Project as on January 18, 2023. 

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

In terms of earlier intimation about winning of a Tender to develop, operate and maintain Radiology Imaging Diagnostic Center at Government Multi Specialty Hospital, Sector - 16, Chandigarh in the month of February, 2022, Krsnaa Diagnostics has informed that the Company has operationalized its Diagnostics Center for providing MRI Services at the allocated place.

The above information is a part of company’s filings submitted to BSE.

This is the Second Diagnostics Center operationalized by the Company out of 8 Diagnostics Centers to be established as a part of the agreement with GOUP

Krsnaa Diagnostics is currently trading at Rs. 420.75, up by 0.35 points or 0.08% from its previous closing of Rs. 420.40 on the BSE.

The scrip opened at Rs. 433.00 and has touched a high and low of Rs. 433.00 and Rs. 420.00 respectively. So far 892 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 693.55 on 28-Jan-2022 and a 52 week low of Rs. 411.00 on 27-Jan-2023.

Last one week high and low of the scrip stood at Rs. 438.00 and Rs. 411.00 respectively. The current market cap of the company is Rs. 1319.96 crore.

The promoters holding in the company stood at 27.80%, while Institutions and Non-Institutions held 23.55% and 48.66% respectively.

Krsnaa Diagnostics has operationalized 1 Diagnostics Center at District Hospital - Male Akbarpur, Kanpur Dehat Uttar Pradesh. This is the Second Diagnostics Center operationalized by the Company out of 8 Diagnostics Centers to be established as a part of the agreement with Department of Medical, Health & Family Welfare, Government of Uttar Pradesh (GOUP).

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

The tender is for Establish & Operate the Laboratory setup in a Hub & Spoke Model at various Government Health Institutions in Odisha

Krsnaa Diagnostics is currently trading at Rs. 445.55, up by 10.40 points or 2.39% from its previous closing of Rs. 435.15 on the BSE.

The scrip opened at Rs. 443.95 and has touched a high and low of Rs. 449.75 and Rs. 433.50 respectively. So far 4939 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 678.80 on 10-Feb-2022 and a 52 week low of Rs. 411.00 on 27-Jan-2023.

Last one week high and low of the scrip stood at Rs. 449.75 and Rs. 416.05 respectively. The current market cap of the company is Rs. 1398.92 crore.

The promoters holding in the company stood at 27.80%, while Institutions and Non-Institutions held 23.55% and 48.66% respectively.

Krsnaa Diagnostics has secured tender from Mission Directorate, National Health Mission, Odisha to Establish & Operate the Laboratory setup in a Hub & Spoke Model at various Government Health Institutions in Odisha State on Public Private Partnership (PPP) basis.

The company will set up minimum 5 or more hubs of its own laboratories which shall process samples from all 32 DHH, 33 SDH and 321 Block CHCs i.e. from Collection Centers and will report the cases within the Turnaround time specified against each tests.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krsnaa Diagnostics has submitted clippings of newspaper publication of the Unaudited Financial Results of the Company for the quarter and nine months ended on 31st December, 2022, published in Financial Express (All Editions) and Loksatta (Pune Edition), both dated on 15th February, 2023. Financial Statement for the quarter and nine months ended as mentioned above has also been published on website (www.krsnaadiagnostics.com) of the Company.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Krsnaa Diagnostics has informed that it enclosed the schedule of Analyst/Institutional Investor meet to be held on 22nd February, 2023. Schedule is subject to change which may happen due to exigencies on the part of Analyst/ Institutional Investor or the Company.

The above information is a part of company’s filings submitted to BSE.

With this, the Company has completed operationalization of entire Project in the State of Punjab

Krsnaa Diagnostics is currently trading at Rs. 366.00, up by 3.10 points or 0.85% from its previous closing of Rs. 362.90 on the BSE.

The scrip opened at Rs. 365.00 and has touched a high and low of Rs. 366.00 and Rs. 363.20 respectively. So far 2421 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 655.00 on 28-Apr-2022 and a 52 week low of Rs. 354.00 on 28-Feb-2023.

Last one week high and low of the scrip stood at Rs. 386.15 and Rs. 354.00 respectively. The current market cap of the company is Rs. 1139.42 crore.

The promoters holding in the company stood at 27.80%, while Institutions and Non-Institutions held 23.55% and 48.66% respectively.

Krsnaa Diagnostics has operationalized diagnostics center at Fazilka, Punjab, as a part of the Agreement with the Government of Punjab for procurement, operation and maintenance of 25 CT Scanners, 6 new MRI Machines, 30 Pathological Laboratories, 1 Referral Laboratory and 95 Collection Centers across the State of Punjab. With this, the Company has completed operationalization of entire Project in the State of Punjab.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

In terms of earlier intimation about winning of a Tender to provide services of Lab Investigation Facilities under ‘Hinduhridaysamrat Balasaheb Thakeray Chikitsa’ for BMC Dispensaries and Hospitals in Mumbai in the month of January, 2023, Krsnaa Diagnostics has informed that the Company has operationalized 100 more Pathology Collection Centers as on the date of this disclosure.

The above information is a part of company’s filings submitted to BSE.

With this, the company has operationalized 300 Pathology collection center as on the date of March 13, 2023

Krsnaa Diagnostics is currently trading at Rs. 386.70, up by 2.40 points or 0.62% from its previous closing of Rs. 384.30 on the BSE.

The scrip opened at Rs. 401.35 and has touched a high and low of Rs. 412.70 and Rs. 386.00 respectively. So far 10829 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 655.00 on 28-Apr-2022 and a 52 week low of Rs. 354.00 on 28-Feb-2023.

Last one week high and low of the scrip stood at Rs. 422.20 and Rs. 372.35 respectively. The current market cap of the company is Rs. 1222.62 crore.

The promoters holding in the company stood at 27.80%, while Institutions and Non-Institutions held 23.55% and 48.66% respectively.

 Krsnaa Diagnostics has operationalized 100 more Pathology Collection Centers in Mumbai. With this, the Company has operationalized 300 Pathology collection center as on the date of March 13, 2023.

Earlier, the company had secured tender from Brihanmumbai Municipal Corporation, Mumbai, Maharashtra to provide services of Lab Investigation Facilities under ‘Hinduhridaysamrat Balasaheb Thakeray Chikitsa’ for BMC Dispensaries and Hospitals in Mumbai, Maharashtra on Public Private Partnership (PPP) basis.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

Quarterly Results

Quarterly Results

Final Dividend & Audited Results

Quarterly Results

Quarterly Results

The company will strengthen its footprint across Maharashtra, Himachal Pradesh, Punjab, West Bengal, and Rajasthan

Krsnaa Diagnostics is planning to launch 600 diagnostics centers across India. The company will strengthen its footprint across Maharashtra, Himachal Pradesh, Punjab, West Bengal, and Rajasthan, with the spread across metros, tier 2 and tier 3 cities.

The centers will be equipped to offer specialized services in precision medicine, genetics, genomics, and molecular diagnostics, along with the routine investigations of biochemistry and serology, which are commonly used in routine diagnostics tests. The centers will offer dedicated services for women’s health (hormones/ PCOD), diabetes monitoring, cardiac health, and cancer care.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

Out of 8 Diagnostics Centers to be established as a part of the Agreement with Department of Medical, Health & Family Welfare GOUP

Krsnaa Diagnostics has operationalized 1 diagnostics center at Lokbandhu Hospital, Lucknow Uttar Pradesh out of 8 Diagnostics Centers to be established as a part of the Agreement with Department of Medical, Health & Family Welfare, Government of Uttar Pradesh (GOUP).

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

The company has operationalized diagnostics center at Ferozepur, Gurdaspur, Nawanshahr and Kapurthala

Krsnaa Diagnostics has operationalized diagnostics center at four more locations i.e. Ferozepur, Gurdaspur, Nawanshahr and Kapurthala in the state of Punjab, as a part of the Agreement with the Government of Punjab for procurement, operation and maintenance of 25 CT Scanners, 6 new MRI Machines, 30 Pathological Laboratories, 1 Referral Laboratory and 95 Collection Centers across the State of Punjab.

With this, the company has operationalized 24 CT Scanners, 6 MRI Machines, 30 Pathology Labs including 1 Referral Laboratory and 95 Collection Centers in the State of Punjab which amounts to completion of 99% of the Project as on January 18, 2023. 

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

This is the Second Diagnostics Center operationalized by the Company out of 8 Diagnostics Centers to be established as a part of the agreement with GOUP

Krsnaa Diagnostics has operationalized 1 Diagnostics Center at District Hospital - Male Akbarpur, Kanpur Dehat Uttar Pradesh. This is the Second Diagnostics Center operationalized by the Company out of 8 Diagnostics Centers to be established as a part of the agreement with Department of Medical, Health & Family Welfare, Government of Uttar Pradesh (GOUP).

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

The company has secured tender from Brihanmumbai Municipal Corporation

Krsnaa Diagnostics has secured tender from Brihanmumbai Municipal Corporation, Mumbai, Maharashtra to provide services of Lab Investigation Facilities under ‘Hinduhridaysamrat Balasaheb Thakeray Chikitsa’ for BMC Dispensaries and Hospitals in Mumbai, Maharashtra on Public Private Partnership (PPP) basis.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

The company will set up a CT Scan, X-Ray Center and Pathology Lab at Late R. R. Patil Commercial Complex located at Dhule

Krsnaa Diagnostics has entered into an agreement with the Dhule Municipal Corporation, Dhule, Maharashtra for Installation, Operation and Maintenance of Radiology and Pathology Center at Late R. R. Patil Commercial Complex located at Dhule, a City in Maharashtra on Public Private Partnership (PPP) basis.

As per the Tender awarded, the company will set up a CT Scan, X-Ray Center and Pathology Lab at Late R. R. Patil Commercial Complex located at Dhule, a City in Maharashtra to serve the patients falling under the jurisdiction of the Dhule Municipal Corporation, Dhule. The company is expected to commence operations within a period of 6 months after possession of an appropriate site with required facilities to operate both Radiology and Pathology services.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

The tender is for Establish & Operate the Laboratory setup in a Hub & Spoke Model at various Government Health Institutions in Odisha

Krsnaa Diagnostics has secured tender from Mission Directorate, National Health Mission, Odisha to Establish & Operate the Laboratory setup in a Hub & Spoke Model at various Government Health Institutions in Odisha State on Public Private Partnership (PPP) basis.

The company will set up minimum 5 or more hubs of its own laboratories which shall process samples from all 32 DHH, 33 SDH and 321 Block CHCs i.e. from Collection Centers and will report the cases within the Turnaround time specified against each tests.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

The company has inaugurated its third diagnostics center, as a part of the agreement with GOUP

Krsnaa Diagnostics has inaugurated its third diagnostics center in Uttar Pradesh on February 23, 2023, as a part of the agreement with Department of Medical, Health & Family Welfare, Government of Uttar Pradesh (GOUP) for providing CT Scan services in the 8 District Hospitals in the state of Uttar Pradesh.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

With this, the Company has completed operationalization of entire Project in the State of Punjab

Krsnaa Diagnostics has operationalized diagnostics center at Fazilka, Punjab, as a part of the Agreement with the Government of Punjab for procurement, operation and maintenance of 25 CT Scanners, 6 new MRI Machines, 30 Pathological Laboratories, 1 Referral Laboratory and 95 Collection Centers across the State of Punjab. With this, the Company has completed operationalization of entire Project in the State of Punjab.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

The company had secured tender from BMC, Mumbai, Maharashtra to provide services of Lab Investigation Facilities

Krsnaa Diagnostics has operationalized 100 more Pathology Collection Centers in Mumbai. Earlier, the company had secured tender from Brihanmumbai Municipal Corporation, Mumbai, Maharashtra to provide services of Lab Investigation Facilities under ‘Hinduhridaysamrat Balasaheb Thakeray Chikitsa’ for BMC Dispensaries and Hospitals in Mumbai, Maharashtra on Public Private Partnership (PPP) basis.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

With this, the Company has operationalized 300 Pathology collection center as on the date of March 13, 2023

Krsnaa Diagnostics has operationalized 100 more Pathology Collection Centers in Mumbai. With this, the Company has operationalized 300 Pathology collection center as on the date of March 13, 2023.

Earlier, the company had secured tender from Brihanmumbai Municipal Corporation, Mumbai, Maharashtra to provide services of Lab Investigation Facilities under ‘Hinduhridaysamrat Balasaheb Thakeray Chikitsa’ for BMC Dispensaries and Hospitals in Mumbai, Maharashtra on Public Private Partnership (PPP) basis.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.

The said tender is for providing Laboratory Services under Free Diagnostics Initiative on HUB and SPOKE Model under NHM in the entire State of Rajasthan

Krsnaa Diagnostics has been qualified as a L1 Bidder with regards to tender in consortium with Telecommunications Consultants India with the Tender Estimated Size of Rs 450 crore by the National Health Mission (NHM), Rajasthan for providing Laboratory Services under Free Diagnostics Initiative on HUB and SPOKE Model under NHM in the entire State of Rajasthan.

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.